N-(3-(1H-Imidazol-1-yl)propyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide manufacturers
- JNJ-9350
-
-
2026-07-14
- CAS:326923-09-5
- Purity: 98.56%
- Supply Ability: 10g
|
| | N-(3-(1H-Imidazol-1-yl)propyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide Basic information |
| | N-(3-(1H-Imidazol-1-yl)propyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide Chemical Properties |
| density | 1.28±0.1 g/cm3(Predicted) | | solubility | DMSO: Sparingly Soluble: 1-10 mg/ml Methanol: Slightly Soluble: 0.1-1 mg/ml | | form | Solid | | pka | 10.08±0.46(Predicted) | | color | White to light brown |
| | N-(3-(1H-Imidazol-1-yl)propyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide Usage And Synthesis |
| Uses | JNJ-9350 is an inhibitor of spermine oxidase (SMOX) with an IC50 value of 0.01 μM. JNJ-9350 also inhibits polyamine oxidase (PAO) with an IC50 value of 0.79 μM. JNJ-9350 can be used for the research of cancer[1]. | | in vivo | 1.19 Pharmacokinetic Properties of JNJ-9350 in Mice [1]. | Mice PO 10 mg/kg | | Clearance (mL/min/kg) (Total/Unbound) | 73/5217 | | Volume of distribution (L/kg) | 1.7 | | Half-life (min) | 16 | | PPB (Mouse) | 98.6% | | Oral F% | 34% | |
| | References | [1] SMOx PROBE PROPOSAL [2] CÉCILE BECQUART. Exploring Heterocycle-Spermine Conjugates as Modulators of Oncogenic microRNAs Biogenesis[J]. ACS Omega, 2018, 3 12: 16500-16508. DOI: 10.1021/acsomega.8b02681 |
| | N-(3-(1H-Imidazol-1-yl)propyl)-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide Preparation Products And Raw materials |
|